Market Access Global comparator data signal “alarm bells” for UK Governmen... Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI.
Views & Analysis Beyond Brexit: how the UK can continue to attract foreign in... The UK will remain a world-class place for life sciences, regardless of Brexit – but overseas companies can benefit from experienced guides on how to set up and thrive here, say Mark Edwards an
Views & Analysis Brexit life sciences ‘beauty contest’ underway How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.